Kaye Biotech Inc. had the following equity account balances at December 31, 2019: $ 43,400 Preferred shares, $3.05, non-cumulative, Authorized: 22,400 shares Issued and outstanding: 6,200 shares Common shares, Authorized: Unlimited Issued and outstanding: 91,000 shares Retained earnings 308,003 45,400 On February 1, 2020, 6,200 preferred shares were issued at $8.90 each. The board of directors declared and paid the annual cash dividend on the preferred shares on June 30, 2020, and a 15% common share dividend was declared and distributed on the same day when the market price per common share was $4.80. On October 1, 2020, 22,400 common shares were issued at $4.94 each. Profit earned during 2020 was $420,800. Required: Using the information provided, prepare the statement of changes in equity for the year ended December 31, 2020. (Amounts to be deducted should be indicated by a minus sign.) KAYE BIOTECH INC. Statement of Changes in Equity For Year Ended December 31, 2020 Preferred Common Retained Shares Shares Earnings Total Equity Balance, January 1 Balance, December 31 $ 0S 0S 0S 0